London Daily

Focus on the big picture.
Saturday, May 31, 2025

AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration

Britain to become first country to trial AstraZeneca coronavirus antibody treatment

New antibody combination aims to help people with weakened immune systems
A new coronavirus antibody treatment developed by pharmaceutical giant AstraZeneca will begin clinical trials for the first time in the UK.

A volunteer from Wakefield, West Yorkshire, will become the first person in the world to receive the company’s new “antibody cocktail”, which is aimed at people with a weakened immune system who cannot be vaccinated.

The clinical trial programme will test whether the treatment will prevent Covid-19 for up to a year. It will evaluate the safety and effectiveness of a combination of two long-acting monoclonal antibodies, which are man-made proteins that act like natural human antibodies in the immune system.

5,000 volunteers will be recruited into the trial, including 1,000 people from nine sites in the UK.

Sir Mene Panaglos, executive vice president of biopharmaceutical research and development at AstraZeneca, said: “There is going to be a significant number of people - even in a world where vaccines are highly effective - who will not respond to vaccines, or in fact will not take vaccines.

“So having monoclonal antibodies as potential therapeutics is also important.”

He called for people, especially vulnerable people over the age of 60 who are immuno-suppressed, to sign up to the trial. These will include people from health care and care home settings.

The UK Government agreed in principle to secure access to one million doses of the antibody treatment, dubbed AZD7442, if it produces successful results in the phase three trials.

Kate Bingham, chairwoman of the UK’s Vaccine Taskforce, said the treatment will be part of the UK’s Covid protection portfolio.

“So, obviously, vaccines work in people who have a functional immune system,” she said. “[But] if you are immuno-suppressed, and you are going through bone marrow transplants, or indications or treatments that actually reduce your ability to mount an immune response, then this is basically the only current way of providing that short-term passive immunity.

“So we are absolutely looking to protect those people who are immuno-suppressed or those people who need immediate protection, because you will remember that vaccines typically take about six weeks to work.”

The NHS Vaccine Research Registry, which comprises a list of 340,000 volunteers willing to take part in clinical trials, will provide some patients for AstraZeneca’s trial.

Sir Mene explained that the two antibodies have been engineered with a life-extension technology to make them effective for longer.

Scientists think the combination will provide protection for at least six months, but closer to 12 months. He described it as a “passive vaccination”.

It is unclear how much the treatment will cost, but Sir Mene said it will be “more expensive than vaccines”, adding: “We hope to make it cost-effective.”

Alok Sharma, the business aecretary, said in a statement: “I am very proud that the UK is the first country in the world to begin this invaluable study, and that a fifth of trial volunteers will be from Britain - a testament to our fantastic life sciences sector and the willingness of our people to come forward to help others.

“As we move closer to a Covid-19 vaccine, we must keep driving forward clinical trials for new and alternative treatments that protect our vulnerable, particularly those who cannot receive a vaccine.

“That is why we have procured one million doses of AstraZeneca’s long-acting antibody treatment if it meets robust safety and effectiveness standards.”
Newsletter

Related Articles

0:00
0:00
Close
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
Italy Faces Population Decline Amid Youth Emigration
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Trump Accuses China of Violating Trade Agreement
Gerry Adams Wins Libel Case Against BBC
Russia Accuses Serbia of Supplying Arms to Ukraine
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
Chinese Woman Dies After Being Forced to Visit Bank Despite Critical Illness
President Trump Grants Full Pardons to Reality TV Stars Todd and Julie Chrisley
Texas Enacts App Store Accountability Act Mandating Age Verification
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Vatican Calls for Sustainable Tourism in 2025 Message
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Trump Threatens 25% Tariff on iPhones Amid Dispute with Apple CEO
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
Liverpool Car Ramming Incident Leaves Multiple Injured
Australia Faces Immigration Debate Following Labor Party Victory
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
Macron Dismisses Viral Video of Wife's Gesture as Playful Banter
Cleveland Clinic Study Questions Effectiveness of Recent Flu Vaccine
Netanyahu Accuses Starmer of Siding with Hamas
Junior Doctors Threaten Strike Over 4% Pay Offer
Labour MPs Urge Chancellor to Tax Wealthy Over Cutting Welfare
Publication of UK Child Poverty Strategy Delayed Until Autumn
France Detains UK Fishing Vessel Amid Post-Brexit Tensions
Calls Grow to Resume Syrian Asylum Claims in UK
Nigel Farage Pledges to Reinstate Winter Fuel Payments
Boris and Carrie Johnson Welcome Daughter Poppy
×